• In these years, Juste strengthened its position in a number of areas:
• Sale of innovative medication in different specialties: Primary Care, Cardiology/hypertension, Gynecology (contraception, osteoporosis), Metabolism and Central Nervous System (epilepsy, migraine, attention deficit hyperactivity disorder, pain, bipolar disorder, multiple sclerosis).
•Founding of Juste Biotech, for R+D into genomic and proteomic diagnostic methods for complex diseases.
• Reinforcement of the Hospital Division of Juste with new launches in the fields of oncology and intensive care.
• Juste acquires the share of the pharmaceutical laboratory SCHERING/BAYER in the joint venture created previously, subsequently strengthening the activity of JUSTESA IMAGEN in R+D and production of active pharmaceutical ingredients.